| Haber: |
Haber Kaynağı: Çeşitli Haber Siteleri
STAT+: Pharmalittle: FDA panel endorses Bluebird Bio gene therapy for rare disease; GSK touts RSV vaccine trial results
GSK will apply for approval for its RSV vaccine for older adults, after reporting data showing the shot is the first to work in adults over 60 in a 25,000-volunteer…
https://www.statnews.com/pharmalot/2022/06/10/covid19-vaccine-rsv-monkeypox-bluebird-gsk-fda-dengue/?utm_campaign=rss
|
